|
GB1555654A
(en)
*
|
1977-06-25 |
1979-11-14 |
Exxon Research Engineering Co |
Agricultural burner apparatus
|
|
US4065562A
(en)
*
|
1975-12-29 |
1977-12-27 |
Nippon Shinyaku Co., Ltd. |
Method and composition for reducing blood glucose levels
|
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
GB2020278B
(en)
*
|
1978-05-03 |
1983-02-23 |
Nippon Shinyaku Co Ltd |
Moranoline dervitives
|
|
JPS568318A
(en)
|
1979-06-28 |
1981-01-28 |
Janssen Pharmaceutica Nv |
Non oral long acting composition of haloperidol and bromperidol derivative
|
|
GB8311286D0
(en)
|
1983-04-26 |
1983-06-02 |
Searle & Co |
Carboxyalkyl peptide derivatives
|
|
EP0144290A3
(de)
|
1983-12-01 |
1987-05-27 |
Ciba-Geigy Ag |
Substituierte Aethylendiaminderivate
|
|
US5041441A
(en)
*
|
1988-04-04 |
1991-08-20 |
The Regents Of The University Of Michigan |
Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
|
|
JPH0416856A
(ja)
|
1990-05-10 |
1992-01-21 |
Canon Inc |
正帯電性非磁性トナー
|
|
US5302609A
(en)
*
|
1992-12-16 |
1994-04-12 |
The Regents Of The University Of Michigan |
Treatment of diabetic nephropathy
|
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
NZ269847A
(en)
*
|
1993-08-13 |
1996-11-26 |
Seikagaku Kogyo Co Ltd |
2-alkylamino-3-morpholino-1-propanol derivative in a composition for neuronal disease treatment
|
|
ES2149350T3
(es)
*
|
1994-02-02 |
2000-11-01 |
Liposome Co Inc |
Compuestos y liposomas farmaceuticamente activos y metodos para su utilizacion.
|
|
DE69524592T2
(de)
*
|
1994-06-10 |
2002-07-18 |
Seikagaku Corp., Tokio/Tokyo |
2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
|
|
WO2001004108A1
(en)
|
1999-07-09 |
2001-01-18 |
Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US5916911A
(en)
*
|
1995-09-20 |
1999-06-29 |
The Regents Of The University Of Michigan |
Amino ceramide--like compounds and therapeutic methods of use
|
|
US20030073680A1
(en)
*
|
1995-09-20 |
2003-04-17 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6890949B1
(en)
*
|
1999-07-09 |
2005-05-10 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6255336B1
(en)
*
|
1995-09-20 |
2001-07-03 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
JP3993908B2
(ja)
|
1995-12-08 |
2007-10-17 |
生化学工業株式会社 |
アミノアルコール誘導体及び該誘導体の製造方法
|
|
NO965193L
(no)
*
|
1995-12-08 |
1997-06-09 |
Seikagaku Kogyo Kk Seikagaku C |
Aminalkoholderivat og fremgangsmåte for fremstilling derav
|
|
JP4140984B2
(ja)
|
1995-12-20 |
2008-08-27 |
生化学工業株式会社 |
分化誘導作用を有する薬剤
|
|
US5972928A
(en)
*
|
1997-05-21 |
1999-10-26 |
Johns Hopkins University |
Methods for treatment of conditions associated with lactosylceramide
|
|
JP4036500B2
(ja)
|
1997-05-23 |
2008-01-23 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
JP4176170B2
(ja)
|
1997-06-06 |
2008-11-05 |
生化学工業株式会社 |
アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬
|
|
US6222619B1
(en)
*
|
1997-09-18 |
2001-04-24 |
University Of Utah Research Foundation |
Diagnostic device and method
|
|
US6465488B1
(en)
*
|
1997-12-11 |
2002-10-15 |
Chancellor, Masters & Scholars Of The University Of Oxford |
Inhibition of glycolipid biosynthesis
|
|
CA2336549A1
(en)
*
|
1998-07-27 |
2000-02-10 |
Johns Hopkins University |
Methods for treating conditions modulated by lactosylceramide
|
|
US6610703B1
(en)
*
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB0100889D0
(en)
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
AU774960B2
(en)
*
|
1999-07-09 |
2004-07-15 |
Regents Of The University Of Michigan, The |
Amino ceramide-like compounds and therapeutic methods of use
|
|
JP5009459B2
(ja)
|
1999-12-06 |
2012-08-22 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
US6407064B2
(en)
|
1999-12-06 |
2002-06-18 |
Seikagaku Corporation |
Aminoalcohol derivative and medicament comprising the same
|
|
US6235737B1
(en)
*
|
2000-01-25 |
2001-05-22 |
Peter Styczynski |
Reduction of hair growth
|
|
AR028023A1
(es)
|
2000-04-19 |
2003-04-23 |
Borody Thomas J |
Una composicion farmaceutica para el tratamiento de la hiperlipidemia y el uso de dicha composicion para la preparacion de medicamentos
|
|
JP2005506949A
(ja)
|
2000-12-20 |
2005-03-10 |
ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー |
ケモカイン受容体の調節剤としてのジアミン
|
|
JP2004523509A
(ja)
|
2000-12-29 |
2004-08-05 |
ワイス |
ベンゾ〔ｇ〕キノリン−３−カルボニトリルの置換体およびベンゾ〔ｇ〕キナゾリンの置換体の位置選択的調製方法
|
|
US20040260099A1
(en)
*
|
2001-01-10 |
2004-12-23 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20020198240A1
(en)
*
|
2001-01-10 |
2002-12-26 |
Shayman James A. |
Amino ceramide - like compounds and therapeutic methods of use
|
|
BR0206400A
(pt)
|
2001-01-10 |
2005-01-18 |
Univ Michigan |
Compostos de amino ceramidas e seus usos em métodos terapêuticos
|
|
US7148251B2
(en)
*
|
2001-01-10 |
2006-12-12 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
ES2395463T3
(es)
|
2001-07-16 |
2013-02-15 |
Genzyme Corporation |
Un inhibidor de N-acilesfingosina glucosiltransferasa
|
|
AU2002348261A1
(en)
*
|
2001-11-26 |
2003-06-10 |
Genzyme Corporation |
Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
|
|
GB0229931D0
(en)
*
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
WO2003057874A1
(fr)
*
|
2001-12-28 |
2003-07-17 |
Sumitomo Pharmaceuticals Company, Limited |
Marqueurs de maladies pour maladies renales et leur utilisation
|
|
GEP20063909B
(en)
|
2002-01-22 |
2006-08-25 |
Warner Lambert Co |
2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d] PYRIMIDIN-7-ONES
|
|
EP1336411A1
(en)
|
2002-02-14 |
2003-08-20 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
|
|
JP2003238410A
(ja)
|
2002-02-21 |
2003-08-27 |
Seibutsu Yuki Kagaku Kenkyusho:Kk |
インスリン抵抗性解除剤
|
|
US20060217560A1
(en)
*
|
2002-04-29 |
2006-09-28 |
Shayman James A |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6916802B2
(en)
*
|
2002-04-29 |
2005-07-12 |
Genzyme Corporation |
Amino ceramide-like compounds and therapeutic methods of use
|
|
JP4575156B2
(ja)
|
2002-07-17 |
2010-11-04 |
アクテリオン ファーマシューティカルズ リミテッド |
グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体
|
|
RS20050035A
(sr)
|
2002-07-17 |
2007-06-04 |
Biogen Idec Ma Inc., |
Terapije bubrežne insuficijencije sa upotrebom interferona -beta
|
|
AU2003225670A1
(en)
|
2003-02-28 |
2004-09-28 |
Intermune, Inc. |
Interferon drug therapy for the treatment of viral diseases and liver fibrosis
|
|
GB0313678D0
(en)
*
|
2003-06-13 |
2003-07-16 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
PT1680112E
(pt)
|
2003-10-29 |
2011-03-24 |
Genzyme Corp |
N-(5-adamantano-1-il-metoxi-pentil)desoxinojirimicina ou um seu sal aceite na indústria farmacêutica para ser usado no tratamento da resistência à insulina
|
|
EP1528056A1
(en)
*
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
EP1711197A4
(en)
|
2003-12-23 |
2008-11-05 |
Musc Found For Res Dev |
METHOD AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES OR CONDITIONS
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
WO2005087023A1
(en)
*
|
2004-03-16 |
2005-09-22 |
Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno |
The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and metabolic syndrome
|
|
EP1576894A1
(en)
*
|
2004-03-16 |
2005-09-21 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and Metabolic Syndrome
|
|
CA2565676C
(en)
|
2004-05-07 |
2013-08-13 |
Samer Elbawab |
Gm3 synthase as a therapeutic target in microvascular complications of diabetes
|
|
US20090111812A1
(en)
|
2004-06-14 |
2009-04-30 |
Musc Foundation For Research Development |
Methods for treating inflammatory disorders
|
|
RU2007110847A
(ru)
*
|
2004-08-20 |
2008-09-27 |
Де Джонс Хопкинс Юниверсити (US) |
Способы лечения ангиогенеза
|
|
US8003617B2
(en)
|
2004-11-10 |
2011-08-23 |
Genzyme Corporation |
Methods of treating diabetes mellitus
|
|
WO2006081273A1
(en)
|
2005-01-26 |
2006-08-03 |
Allergan, Inc. |
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
HUE026057T2
(en)
|
2006-05-09 |
2016-05-30 |
Genzyme Corp |
Procedures for the Treatment of Fatty Liver Disease, which comprises inhibition of glycosphingolipid synthesis
|
|
WO2008011478A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
|
|
WO2008011487A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
|
|
BRPI0806970A2
(pt)
|
2007-02-09 |
2014-04-08 |
Irm Llc |
Compostos e composições como inibidores de protease de ativação de canal
|
|
EP2594563B1
(en)
|
2007-05-31 |
2018-07-18 |
Genzyme Corporation |
2-acylaminopropanol-type glucosylceramide synthase inhibitors
|
|
BRPI0817864A2
(pt)
|
2007-10-05 |
2012-12-25 |
Genzyme Corp |
uso de um composto derivado de ceramida
|
|
WO2009117150A2
(en)
|
2008-03-20 |
2009-09-24 |
Genzyme Corporation |
Method of treating lupus with ceramide derivatives
|
|
US8389517B2
(en)
|
2008-07-28 |
2013-03-05 |
Genzyme Corporation |
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
|
|
WO2010039256A1
(en)
|
2008-10-03 |
2010-04-08 |
Genzyme Corporation |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
|